SCHEMBL20747683

SCHEMBL20747683

CCCCCC(C)(CCCCC)COC(=O)OCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 5/20 0.39
HSD17B10 Q99714 1/20 0.39
TSHR P16473 4/20 0.36
CYP3A4 P08684 2/20 0.36
NFKB1 P19838 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ADRA1A P35348 1/20 0.36
RAB9A P51151 1/20 0.36
SMPD1 P17405 3/20 0.33
CYP2C9 P11712 1/20 0.33
PTGS1 P23219 1/20 0.33
APEX1 P27695 1/20 0.33
THPO P40225 1/20 0.33
PMP22 Q01453 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747622 0.97 MAPT (0.40) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747576 0.97 LMNA (0.44) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747647 0.94 MAPT (0.37) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747725 0.86 MAPT (0.38) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL6896497 0.82 TSHR (0.34) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL6896666 0.79 MAPT (0.37) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL6895400 0.78 LMNA (0.38) MEN1KMT2ALMNAHSD17B10TSHR
SCHEMBL21246104 0.77 LMNA (0.41) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747606 0.76 MAPT (0.35) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL4922984 0.75 NAAA (0.48) MAPTATMTSHRCYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208045-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208045-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK MAPT 3216/4885MEN1 2269/4885KMT2A 1761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.